128 related articles for article (PubMed ID: 3810527)
1. [Comparative organization of drug monitoring in France and 7 European countries].
Vaissere J; de Cremiers F; Auriche M; Juillet Y
Therapie; 1986; 41(5):369-74. PubMed ID: 3810527
[No Abstract] [Full Text] [Related]
2. [Drug monitoring].
Royer RJ
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():11-30. PubMed ID: 4064240
[No Abstract] [Full Text] [Related]
3. [Drug surveillance as seen by the general practitioner. Apropos of a survey of 4175 physicians].
Begaud B; Haramburu F; Péré JC; Delmas N; Lorson B; Albin H
Therapie; 1984; 39(5):453-7. PubMed ID: 6506000
[No Abstract] [Full Text] [Related]
4. [Computerized detection of new adverse effects in drug surveillance. A proposal for the periodic use of the French data bank].
Pham E; Ventre JJ; Saddier P; Descotes J; Evreux JC
Therapie; 1988 May; 43(3):235-7. PubMed ID: 3420571
[No Abstract] [Full Text] [Related]
5. [Mandatory report of adverse effects of drugs: has the order modified the spontaneous notification?].
Haramburu F; Pere JC; Begaud B; Albin H
Therapie; 1988; 43(6):493-6. PubMed ID: 3227516
[No Abstract] [Full Text] [Related]
6. European commission consultation on pharmacovigilance.
Waller P; Beard K; Egberts T; Evans S; Hallas J; Hasford J; Laporte JR; Moore N; Shakir S; Sturkenboom M
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):108-9. PubMed ID: 18058839
[No Abstract] [Full Text] [Related]
7. Monitoring adverse drug reactions in the postmarketing phase.
Hoigné R; Hottinger S
Pharm Acta Helv; 1988; 63(1):2-12. PubMed ID: 3283774
[No Abstract] [Full Text] [Related]
8. [Information centers on undesirable effects of drugs: also on alerting function].
Bégaud B; Péré JC; Tubert P; Barat C; Haramburu F; Albin H
Therapie; 1987; 42(2):231-7. PubMed ID: 3617000
[No Abstract] [Full Text] [Related]
9. [Advantages of a microcomputer system in researching duplicated reports].
Biour M; Wagniart F; Jablonka J; Hamel JD; Weissenburger J; Cheymol G
Therapie; 1986; 41(5):383-4. PubMed ID: 3810530
[No Abstract] [Full Text] [Related]
10. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
Lagier G; Vincens M; Lefebure B; Frelon JH
Therapie; 1983; 38(3):295-302. PubMed ID: 6612666
[No Abstract] [Full Text] [Related]
11. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
[TBL] [Abstract][Full Text] [Related]
12. Measuring adverse drug reactions in a postmarketing surveillance system.
Fisher S; Bryant SG; Kluge RM
Psychopharmacol Bull; 1986; 22(1):272-7. PubMed ID: 3726073
[No Abstract] [Full Text] [Related]
13. [Necessity and difficulties of quantitative drug monitoring].
Lagier G; Dally S; Vincens M; Castot A
Therapie; 1983; 38(3):319-23. PubMed ID: 6612668
[No Abstract] [Full Text] [Related]
14. [Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid].
Lagier G; Vincens M; Castot A
Therapie; 1983; 38(3):303-18. PubMed ID: 6612667
[No Abstract] [Full Text] [Related]
15. Current status of the drug safety monitoring system in Korea.
Park BJ
Pharmacoepidemiol Drug Saf; 2001; 10(6):557-60. PubMed ID: 11828840
[No Abstract] [Full Text] [Related]
16. FDA attempting to overcome major roadblocks in monitoring drug safety.
Zielinski SL
J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
[No Abstract] [Full Text] [Related]
17. Statewide test of a new postmarketing drug surveillance system.
Fisher S; Bryant SG; Solovitz BL; Kluge RM
Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
[No Abstract] [Full Text] [Related]
18. [Responsibility of the pharmaceutical industry toward the first undesirable effects of new products].
Juillet Y; de Cremiers F
Therapie; 1988; 43(5):385-8. PubMed ID: 3227498
[No Abstract] [Full Text] [Related]
19. [Seventh French Drug Surveillance Seminar. Caen, 21-22 November 1985].
Therapie; 1986; 41(5):323-84. PubMed ID: 3810518
[No Abstract] [Full Text] [Related]
20. [Eighth French Drug Surveillance Seminar. Paris, 23-24 October 1986].
Therapie; 1987; 42(4):331-410. PubMed ID: 3686465
[No Abstract] [Full Text] [Related]
[Next] [New Search]